{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:09:28Z","timestamp":1788998968517,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2017GXNSFAA198369"],"award-info":[{"award-number":["2017GXNSFAA198369"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.12.025","type":"journal-article","created":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T07:43:28Z","timestamp":1577519008000},"page":"1804-1809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China"],"prefix":"10.1016","volume":"38","author":[{"given":"Lina","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weitao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyi","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2019.12.025_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1473-3099(13)70342-6","article-title":"Hand, foot, and mouth disease in China, 2008\u201312: an epidemiological study","volume":"14","author":"Xing","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2019.12.025_b0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/eri.09.45","article-title":"Enterovirus 71: epidemiology, pathogenesis and management","volume":"7","author":"Wang","year":"2009","journal-title":"Exp Rev Anti Infect Ther"},{"issue":"12","key":"10.1016\/j.vaccine.2019.12.025_b0015","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMoa065954","article-title":"Neurodevelopment and cognition in children after enterovirus 71 infection","volume":"356","author":"Chang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.12.025_b0020","doi-asserted-by":"crossref","first-page":"23444","DOI":"10.1038\/srep23444","article-title":"Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease","volume":"6","author":"Long","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2019.12.025_b0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-0033-1360480","article-title":"Neurological images and the predictors for neurological sequelae of epidemic herpangina\/hand-foot-mouth disease with encephalomyelitis","volume":"45","author":"Tsai","year":"2014","journal-title":"Neuropediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2019.12.025_b0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/rmv.1827","article-title":"Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014","volume":"25","author":"Liu","year":"2015","journal-title":"Rev Med Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.12.025_b0035","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1303224","article-title":"An inactivated enterovirus 71 vaccine in healthy children","volume":"370","author":"Li","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2019.12.025_b0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1304923","article-title":"Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China","volume":"370","author":"Zhu","year":"2014","journal-title":"N Engl J Med"},{"issue":"9882","key":"10.1016\/j.vaccine.2019.12.025_b0045","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.12.025_b0050","first-page":"1","article-title":"Enterovirus A71 vaccine effectiveness in preventing enterovirus A71 infection among medically-attended hand, foot, and mouth disease cases, Beijing, China","author":"Wang","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"04","key":"10.1016\/j.vaccine.2019.12.025_b0055","first-page":"340","article-title":"Epidemiological characteristics and temporal-spatial clustering of hand, foot and mouth disease in Guangxi from 2008 to 2015","volume":"21","author":"Jing","year":"2017","journal-title":"Chinese J Dis Control Prevent"},{"issue":"30","key":"10.1016\/j.vaccine.2019.12.025_b0060","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/j.vaccine.2013.04.026","article-title":"The case test-negative design for studies of the effectiveness of influenza vaccine","volume":"31","author":"Foppa","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.025_b0065","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/1743-422X-9-248","article-title":"Seroepidemiology of human enterovirus71 and coxsackievirusA16 in Jiangsu province","volume":"9","author":"Ji","year":"2012","journal-title":"China Virol J"},{"issue":"12","key":"10.1016\/j.vaccine.2019.12.025_b0070","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/INF.0000000000000900","article-title":"Seroprevalence of enterovirus 71 antibody among children in China: a systematic review and meta-analysis","volume":"34","author":"Yang","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.12.025_b0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/14760584.2018.1430572","article-title":"A comparative analysis of immunogenicity and safety of an enterovirus 71 vaccine between children aged 3\u20135 years and infants aged 6\u201335 months","volume":"17","author":"Gu","year":"2018","journal-title":"Exp Rev Vacc"},{"issue":"2","key":"10.1016\/j.vaccine.2019.12.025_b0080","doi-asserted-by":"crossref","first-page":"e1001958","DOI":"10.1371\/journal.pmed.1001958","article-title":"Hand, foot, and mouth disease in China: modeling epidemic dynamics of enterovirus serotypes and implications for vaccination","volume":"13","author":"Takahashi","year":"2016","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.12.025_b0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14760584.2016.1096782","article-title":"Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vacc"},{"issue":"1","key":"10.1016\/j.vaccine.2019.12.025_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/ceji.2019.84009","article-title":"A Bacillus-based Coxsackie virus A16 mucosal vaccine induces strong neutralizing antibody responses","volume":"44","author":"Cao","year":"2019","journal-title":"Cent Eur J Immunol"},{"issue":"15","key":"10.1016\/j.vaccine.2019.12.025_b0095","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1016\/j.vaccine.2011.01.094","article-title":"Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine","volume":"29","author":"Chen","year":"2011","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2019.12.025_b0100","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.vaccine.2017.07.003","article-title":"Basic principles of test-negative design in evaluating influenza vaccine effectiveness","volume":"35","author":"Fukushima","year":"2017","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.12.025_b0105","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.vaccine.2015.01.069","article-title":"Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness","volume":"33","author":"Jackson","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.12.025_b0110","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.vaccine.2010.10.082","article-title":"Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR)","volume":"29","author":"Coleman","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.12.025_b0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/aje\/kwx251","article-title":"Estimating influenza vaccine effectiveness with the test-negative design using alternative control groups: a systematic review and meta-analysis","volume":"187","author":"Feng","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.12.025_b0120","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.vaccine.2017.12.022","article-title":"The impact of selection bias on vaccine effectiveness estimates from test-negative studies","volume":"36","author":"Jackson","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.12.025_b0125","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1038\/srep08904","article-title":"Epidemiological and etiological characteristics of hand, foot, and mouth disease in Henan, China, 2008\u20132013","volume":"5","author":"Huang","year":"2015","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2019.12.025_b0130","doi-asserted-by":"crossref","first-page":"e139109","DOI":"10.1371\/journal.pone.0139109","article-title":"Epidemiological characteristics and spatial-temporal clusters of hand, foot, and mouth disease in Zhejiang province, China, 2008\u20132012","volume":"10","author":"Gui","year":"2015","journal-title":"PLoS ONE"},{"issue":"50","key":"10.1016\/j.vaccine.2019.12.025_b0135","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2017.22.50.16-00824","article-title":"Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine","volume":"22","author":"Yang","year":"2017","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.vaccine.2019.12.025_b0140","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/jmv.25393","article-title":"Ongoing change of severe hand, foot, and mouth disease pathogens in Yunnan, China, 2012 to 2016","volume":"91","author":"Du","year":"2019","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.12.025_b0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088065","article-title":"Spatio-temporal clustering of hand, foot, and mouth disease at the county level in Guangxi, China","volume":"9","author":"Xie","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.vaccine.2019.12.025_b0150","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/INF.0000000000000794","article-title":"Prevalence of coxsackievirus A6 and enterovirus 71 in hand, foot and mouth disease in Nanjing, China in 2013","volume":"34","author":"Hu","year":"2015","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2019.12.025_b0155","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/cid\/ciu624","article-title":"Severe hand, foot, and mouth disease and coxsackievirus A6-Shenzhen","volume":"59","author":"Yang","year":"2014","journal-title":"China Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.12.025_b0160","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1080\/23744235.2016.1185801","article-title":"Risk factors for death in children with severe hand, foot, and mouth disease in HunanChina","volume":"48","author":"Long","year":"2016","journal-title":"Infect Dis (Lond)"},{"issue":"6","key":"10.1016\/j.vaccine.2019.12.025_b0165","doi-asserted-by":"crossref","first-page":"e1785","DOI":"10.1542\/peds.2006-1547","article-title":"Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children","volume":"118","author":"Huang","year":"2006","journal-title":"Pediatrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19316676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:16Z","timestamp":1759401676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19316676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0264410X19316676"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.025","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}